Beam Therapeutics Inc. (BEAM) › Shareholders' EquityBeam Therapeutics Inc. (BEAM) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$117.41M2019: -$201.10M2020: $245.56M2021: $826.74M2022: $733.47M2023: $981.33M2024: $733.54M2025: $1.24B$1.24B2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$1.24B+68.8%2024$733.54M-25.2%2023$981.33M+33.8%2022$733.47M-11.3%2021$826.74M+236.7%2020$245.56M+222.1%2019-$201.10M-71.3%2018-$117.41M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share